HighTower Advisors’s Inari Medical, Inc. Common Stock NARI Stock Holding History

HighTower Advisors’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-62,202	Closed	-$3.18M	–	4107
2024 Q4	$3.18M	Buy	62,202 +234	+0.4%	+$11.5K	﹤0.01%	1264
2024 Q3	$2.56M	Sell	61,968 -3,901	-6%	-$187K	﹤0.01%	1370
2024 Q2	$3.17M	Buy	65,869 +132	+0.2%	+$5.85K	﹤0.01%	1206
2024 Q1	$3.16M	Buy	65,737 +4,446	+7%	+$238K	0.01%	1187
2023 Q4	$3.98M	Buy	+61,291	New	+$3.69M	0.01%	1085
2021 Q1	–	Sell	-9,079	Closed	-$792K	–	3294
2020 Q4	$792K	Buy	+9,079	New	+$641K	﹤0.01%	1388

Other funds holding NARI

SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

HighTower Advisors's NARI Position: Q1 2025 in Review

HighTower Advisors sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 62,202 shares — an estimated $3.18M sold.

HighTower Advisors first reported a position in NARI in Q4 2020 and held it in 6 quarters. The position peaked at $3.98M in Q4 2023. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

HighTower Advisors reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
HighTower Advisors sold 62,202 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $3.18M.
HighTower Advisors first reported a position in Inari Medical, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
HighTower Advisors's Inari Medical, Inc. Common Stock position peaked at $3.98M in Q4 2023.
4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on HighTower Advisors's 13F filing for Q1 2025, filed 13 May 2025.